ArticleBiomedical chromatography : BMC2026
Exploring GC-MS-Based Phytochemistry and Network Pharmacology to Elucidate the Multi-Target Therapeutic Potential of Betel Leaf Oil as an Analgesic and Anti-Inflammatory Agent.
Article in Biomedical chromatography : BMC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Betel leaf (Piper betle L.) has been widely used in traditional medicine for treating pain, inflammation, and microbial infections due to its rich phytochemical content. However, the molecular mechanisms underlying its analgesic and anti-inflammatory effects remain incompletely understood. This study aimed to analyze the phytochemical composition of betel leaf oil using GC-MS and to explore its therapeutic mechanisms through network pharmacology targeting genes involved in pain and inflammation pathways. Betel leaf essential oil was extracted and analyzed with GC-MS to identify bioactive metabolites. The identified compounds were further examined using network pharmacology to predict target genes and develop compound-protein interaction networks. Gene ontology enrichment, DisGeNET disease enrichment, and gene-disease association analyses were conducted to investigate biological pathways and disease relevance. The GC-MS analysis revealed bioactive compounds including estragole, oleic acid, chavicol acetate, and eugenol, interacting strongly with genes such as SCN9A, SCN10A, TRPV1, ICAM1, STAT3, TNF, and BDNF involved in pain and inflammatory responses. The findings suggest that the bioactive components of betel leaf oil may possess analgesic and anti-inflammatory properties, indicating its potential as a source of therapeutic agents. Molecular docking further demonstrated favorable binding of eugenol and oleic acid with TNF-α and TRPV1, supporting their potential anti-inflammatory and analgesic activities. These integrated findings suggest that the bioactive constituents of betel leaf oil possess potential analgesic and anti-inflammatory activities through multi-target interactions, although further experimental validation is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.